Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Anja von Heydebreck | Researchclopedia

Back to researchers

Anja von Heydebreck

Merck (Germany)

124

Works

10,771

Citations

41

h-index

70

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Gene expression and cancer classification Gastrointestinal Tumor Research and Treatment

Affiliations

Semmelweis University2016–2016

Goethe University Frankfurt2003–2003

University of Miami2016–2016

University of Antwerp2016–2016

Max Planck Society2002–2005

Top Works

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

Wolfgang Huber,Anja von Heydebreck,et al.

20022,540 citations

Lung Cancer Treatments and Mutations

Polyomavirus and related diseases

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Howard L. Kaufman,Jeffery S. Russell,et al.

20161,207 citations

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Luc Dirix,István Takács,et al.

2017750 citations

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

Robert Pirker,Jose R. Pereira,et al.

2011573 citations

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer

Mary L. Disis,Matthew H. Taylor,et al.

2019422 citations

Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis

Verena Brune,Enrico Tiacci,et al.

2008361 citations

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Howard L. Kaufman,Jeffery S. Russell,et al.

2018328 citations

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Christopher R. Heery,Geraldine O’Sullivan Coyne,et al.

2017293 citations

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

James L. Gulley,Arun Rajan,et al.

2017283 citations